Back

Empagliflozin-related DRESS syndrome

European Heart Journal - Case Reports

24 June 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE HEART FAILURE Chronic Heart Failure PREVENTIVE CARDIOLOGY Risk Factors and Prevention
You may be interested in
thumbnail
Congress Presentation
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results
29 June 2021
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure
17 May 2025
thumbnail
Congress Presentation
From epigastric pain to heart transplant: navigating DRESS-induced myocarditis
1 September 2024
thumbnail
Congress Session
No time like the present: heart failure in the hospital setting
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources